Sana Biotechnology (SANA) Enterprise Value (2020 - 2026)
Sana Biotechnology (SANA) reported Enterprise Value of -$101.1 million for Q1 2026, up 3.4% on a YoY basis from -$97.8 million in Q1 2025, and down 32.96% sequentially from -$76.1 million in Q4 2025.
Sana Biotechnology (SANA) Enterprise Value (2020 - 2026) Analysis & Trends
Sana Biotechnology (SANA) has 7 years of Enterprise Value data on file, last reported at -$101.1 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value rose 3.4% year-over-year to -$101.1 million; the trailing twelve-month figure through Mar 2026 stood at -$101.1 million (up 3.4% YoY), and the FY2025 full-year result was -$76.1 million, up 42.11% from the prior year.
- Enterprise Value slipped to -$101.1 million in Q1 2026, from -$76.1 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$72.7 million in Q2 2025 to a low of -$512.4 million in Q1 2022.
- A 5-year average of -$186.1 million and a median of -$166.6 million in 2023 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value jumped 71.93% in 2022 and tumbled 39.42% in 2024, its largest moves.
- Tracing SANA's Enterprise Value over 5 years: stood at -$182.9 million in 2022, then rose by 24.89% to -$137.3 million in 2023, then rose by 4.33% to -$131.4 million in 2024, then soared by 42.11% to -$76.1 million in 2025, then sank by 32.96% to -$101.1 million in 2026.
- Business Quant data shows SANA's Enterprise Value at -$101.1 million in Q1 2026, -$76.1 million in Q4 2025, and -$107.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Sana Biotechnology | 888.71 Mn | 888.71 Mn | - | -101.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -101.14 Mn |
| Dec 31, 2025 | -76.07 Mn |
| Sep 30, 2025 | -107.55 Mn |
| Jun 30, 2025 | -72.67 Mn |
| Mar 31, 2025 | -104.70 Mn |
| Dec 31, 2024 | -131.40 Mn |
| Sep 30, 2024 | -130.83 Mn |
| Jun 30, 2024 | -251.64 Mn |
| Mar 31, 2024 | -180.89 Mn |
| Dec 31, 2023 | -137.35 Mn |
| Sep 30, 2023 | -172.28 Mn |
| Jun 30, 2023 | -180.49 Mn |
| Mar 31, 2023 | -166.56 Mn |
| Dec 31, 2022 | -182.87 Mn |
| Sep 30, 2022 | -169.44 Mn |
| Jun 30, 2022 | -484.80 Mn |
| Mar 31, 2022 | -512.38 Mn |
| Dec 31, 2021 | -551.00 Mn |
| Sep 30, 2021 | -603.71 Mn |
| Jun 30, 2021 | -852.84 Mn |